Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

STEROIDAL DRUGS IN ENDOMETRIOSIS.

A J I Kauppila1, S Telimaa1, L Rönnberg1

  • 1From the Department of Obstetrics and Gynecology, University of Oulu, Finland.

Acta Obstetricia Et Gynecologica Scandinavica
|November 11, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salivary and serum progesterone concentrations during two luteal support regimens used in in vitro fertilization treatment.

Fertility and sterility·2001
Same author

Mental impairment and utilization of community services: a study of the elderly in a parish of Stockholm.

Scandinavian journal of social medicine·1996
Same author

Bacterial attachment to oropharyngeal epithelial cells in breastfed newborns.

International journal of pediatric otorhinolaryngology·1996
Same author

Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis.

Fertility and sterility·1996
Same author

The short human figure drawing scale for evaluation of suspect cognitive dysfunction in old age.

Archives of gerontology and geriatrics·1994
Same author

The perceived importance of appearance and oral function, comfort and health for severely demented persons rated by relatives, nursing staff and hospital dentists.

Gerodontology·1994
Same journal

The uterine scar dilemma: Outcomes of a restricted elective repeat cesarean section policy in a high-fertility, resource-limited setting.

Acta obstetricia et gynecologica Scandinavica·2026
Same journal

Prospective evaluation of the Simple Fetal Medicine Foundation's first-trimester prediction model for preeclampsia in twin pregnancies.

Acta obstetricia et gynecologica Scandinavica·2026
Same journal

Externally validated risk prediction models for gestational diabetes mellitus: A systematic review and meta-analysis.

Acta obstetricia et gynecologica Scandinavica·2026
Same journal

Prenatal exome sequencing of fetuses with central nervous system anomalies based on prenatal ultrasound and magnetic resonance imaging diagnosis: A retrospective cohort study with a systematic review and meta-analysis.

Acta obstetricia et gynecologica Scandinavica·2026
Same journal

Active surveillance of cervical intraepithelial neoplasia and adverse pregnancy outcomes: A register-based cohort study.

Acta obstetricia et gynecologica Scandinavica·2026
Same journal

Commentary on central sensitization in chronic pelvic pain.

Acta obstetricia et gynecologica Scandinavica·2026
See all related articles

Medroxyprogesterone acetate (MPA) and danazol effectively treat endometriosis symptoms and lesions. However, their indirect hormonal actions are key, and they are not ideal for endometriosis-related infertility.

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Pharmacology

Background:

  • Endometriosis is managed with progestins like medroxyprogesterone acetate (MPA), danazol, and gestrinone.
  • These drugs exhibit progestin-like effects on the endometrium, but ectopic tissue shows limited response.
  • Therapeutic effects may stem from indirect actions on the hypothalamic-pituitary-ovarian axis.

Purpose of the Study:

  • To compare the clinical efficacy and side effects of danazol and high-dose MPA in endometriosis management.
  • To evaluate the impact of these hormonal therapies on fertility outcomes in infertile patients with endometriosis.

Main Methods:

  • A 6-month randomized trial comparing danazol, MPA, and placebo for endometriosis.
  • Assessment of symptom relief, lesion disappearance, and androgenic/metabolic side effects.
Keywords:
Endometriosisdanazolgestrinonehormonal therapyinfertilitymedroxyprogesterone acetate

Related Experiment Videos

  • Long-term follow-up to determine cumulative pregnancy rates in infertile patients.
  • Main Results:

    • Danazol and MPA demonstrated equal clinical efficacy in treating endometriosis symptoms and lesions.
    • Danazol therapy was associated with more androgenic and metabolic side effects compared to MPA.
    • No significant difference in cumulative pregnancy rates was observed between danazol, MPA, and placebo groups; hormonal therapy delayed conception.

    Conclusions:

    • Both danazol and MPA are effective for endometriosis, with indirect hormonal suppression being a primary mechanism.
    • Danazol and MPA are not recommended as first-line treatments for endometriosis-associated infertility.
    • Further research into managing infertility in endometriosis patients is warranted.